Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
48M
-
Number of holders
-
192
-
Total 13F shares, excl. options
-
45.2M
-
Shares change
-
-1.42M
-
Total reported value, excl. options
-
$1.13B
-
Value change
-
-$35.2M
-
Put/Call ratio
-
0.49
-
Number of buys
-
90
-
Number of sells
-
-68
-
Price
-
$25.04
Significant Holders of BIOLIFE SOLUTIONS INC - Common Stock, par value $0.001 per share (BLFS) as of Q3 2024
200 filings reported holding BLFS - BIOLIFE SOLUTIONS INC - Common Stock, par value $0.001 per share as of Q3 2024.
BIOLIFE SOLUTIONS INC - Common Stock, par value $0.001 per share (BLFS) has 192 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 45.2M shares
of 48M outstanding shares and own 94.05% of the company stock.
Largest 10 shareholders include Casdin Capital, LLC (8.71M shares), BlackRock, Inc. (5.52M shares), Invesco Ltd. (3.2M shares), VANGUARD GROUP INC (2.85M shares), FRED ALGER MANAGEMENT, LLC (1.58M shares), STATE STREET CORP (1.41M shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (1.15M shares), CRAMER ROSENTHAL MCGLYNN LLC (1.1M shares), GENEVA CAPITAL MANAGEMENT LLC (865K shares), and Voya Investment Management LLC (862K shares).
This table shows the top 192 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.